Hepatobiliary & Pancreatic Diseases International

Hepatobiliary & Pancreatic Diseases International

Copyright 2017, Hepatobiliary & Pancreatic Diseases International. All rights reserved.www.hbpdint.com

General information

Hepatobiliary & Pancreatic Diseases Internationalis a journal published bimonthly in the English language by the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. We welcome original research articles, review articles, editorials, and others from any part of the world. Manuscripts are reviewed by members of the international editorial board and our expert peer reviewers, then either accepted for publication or rejected by the chief editor.Manuscripts should be submitted viahttps://mc03.manuscriptcentral.com/hbpdint.

Most of submissions accepted for publication may undergo revisions recommended by the reviewers, editors or statistical advisers. A decision takes from two weeks to three months, the longer period being due to the multiple reviews needed for articles likely to be accepted. Publication varies from two to six months aer final acceptance.Proofs of edited articles and illustrations are sent to the corresponding author for correction and reply to any queries from editors. A sample copy of the journal containing the articles will be forwarded to the corresponding author within a few days of publication.

Online submissions

Original research articlesincluding randomized trials,intervention studies, studies of screening and diagnostic tests,cohort studies, cost-effectiveness analyses and case control studies should be prepared in accordance with theUniform Requirements for Manuscripts Submitted to Biomedical Journals (www.icmje.org).ose of randomized controlled trials (RCTs) should follow the CONSORT-statement(www.consort-statement.org).e reporting of other articles should follow the guidelines set by the different initiatives or groups listed in the appendix.e article should be submitted with two separate files, one with detailed information about authors and the title, short running title, source of the work, in addition to the names, address, telephone and fax number or email address for the corresponding author. Another file should show only the title, running title, abstract, main text, tables, figures of the submitted article as well as a list of references, which will be sent to reviewers.

Each submission must be accompanied by a letter of copyright transfer signed by all the authors (see the detailed description in the last section) and other relevant documents including informed consent obtained from research subjects and research approval from the supervising or institutional ethics bodies. Author(s) of each submission should clarify the functions in or contributions to their research and declare, if any, competing interest. A choice of one of the following statements will be requested when a decision has been made to accept the paper:

Manuscripts should be prepared with generous margins, and double spacing is essential throughout the text,the references and the captions. Tables, figures, captions and list of references should appear properly in the text.e style should be simple and direct, free from ambiguity and jargon, and with minimal use of abbreviations.

Structured abstractof original articles should include four sections as Background, Methods, Results and Con-clusions and have no more than 300 words summarizing the most important points in the article, incorporating key words suitable for electronic retrieval systems.Background:is section should provide a precise statement of the primary focus of the study and the context in which it was carried out.Methods:is section describes how the study was performed, including details of clinical and/or technical procedures.Results:is section describes the salient results of the study.Conclusions:is section covers conclusions and their clinical application or others,while equal emphasis should be given to positive and negative findings of equal scientific merit.

Introduction:is should explain the problem which is to be addressed, with a definition of the hypothesis to be examined if appropriate, out-lining, briefly, its relevance to the appropriate literature.

Methods (Materials or Patients):e subjects of the study and the methods employed in the investigation must be clearly described. For example, the reasons for examining the particular group of patients should be made clear,and reasons for exclusion of individuals from the study must be stated. Any group used as controls must be defined accurately.

Ethical approval of studies and informed consent are required. For all manuscripts reporting data from studies involving human participants or animals, formal review and approval, or formal review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section.For those investigators who do not have formal ethics review committees, the principles outlined in theDeclaration of Helsinkishould be followed. For investigations of humans, state in the Methods section the manner in which informed consent was obtained from the study participants (i.e., oral or written). Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study.

Results:ese must be clearly expressed in simple language. Tables or similar diagrams can be used but must not duplicate material already described in the text.

Discussion:is section must be succinct, pointing out the relevance of the work described in the article and its contribution to current knowledge.e results must be interpreted clearly, and both strength and weakness expressed. Discussion of pertinent references must be concise and short.

Each of thetablesshould have a short descriptive heading.

Article from journal—more than one author

Yan S, Zhang QY, Yu YS, He JJ, Wang WL, Zhang M,et al. Microsurgical reconstruction of hepatic artery in living donor liver transplantation: experiences and lessons.Hepatobiliary Pancreat Dis Int 2009;8:575-580. PMID:20007072

Article from journals with English abstracts only

Ma Y, Hu AB, Xiong J. Migration of donor dendritic cell inducing graacceptance in combined transplantation of liver and kidney [abstract in English]. Zhonghua Shi Yan Wai Ke Za Zhi 2006;23:750-752.

Monographic series

DavidoffRA. Migraine: manifestations, pathogenesis,and management. Philadelphia, Pa: FA Davis; 1995. Contemporary Neurology Series, No. 42.

Online journals with volume and page information

Simon JA, Hudes ES. Relationship of ascorbic acid to blood lead levels. JAMA 1999;281:2289-2293. PMID:10386552. Accessed June 11, 2009. http://jama.ama-assn.org/cgi/content/full/281/24/2289

Online journals without volume and page information

Verschuur EM, Steyerberg EW, Tilanus HW, Polinder S, Essink-Bot ML, Tran KT, et al. Nurse-led follow-up ofpatients aer oesophageal or gastric cardia cancer surgery: a randomised trial. Br J Cancer 2008 Dec 9. PMID: 19066612 doi: 10.1038/sj.bjc.6604811

Online website

Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1(1): [24 screens]. Available from: www.cdc.gov/ncidod/eid/vol1no1/morse.htm

Book—more than one author (list all authors if six or less,otherwise list first three followed by et al)

Baselt RC, Cravey RH. Disposition of toxic drugs and chemicals in man, 4th ed. Foster City, CA: Chemical Toxicology Institute;1995.

Chapter from a book

Calne RY. Experimental background. In: Calne RY, ed.Liver transplantation, 2nd ed. London: Grune & stratton;1987:3-7.

Book—with editors

Maddrey WC, ed. Transplantation of the liver. New York: Elsevier Science Publishing;1998.

IllustrationsPhotographs, drawings, diagrams,charts and graphs should meet the editorial demands.e“three-dimensional” bar charts produced by computer programs are not acceptable. Photomicrographs with no inset scale should have the magnification of the print in the caption; stains should be indicated.e lettering on diagrams and graphs should be large enough to be clear aer it has been reduced for printing and be consistent in size and style. Color will be accepted only where it is essential. Permission to reproduce any borrowed illustration must be obtained from the author and the publisher, and evidence of this permission must accompany the submitted article.

Review articlesare welcome especially systematic,critical assessments of the literature and data sources pertaining to clinical topics, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and tests or outcomes. All articles or data sources should be selected systematically for inclusion in the review and critically evaluated, and the selection process should be described in the article.Meta-analyses also will be considered as review articles.Editors ask potential authors of review articles to check the MOOSE initiative for meta-analysis of observational studies in epidemiology (See the appendix).

Letters to the editoron matters of recently published articles in the journal are especially welcome, which should not exceed 400 words. Letters of general interest,unlinked to items published in the journal, can be up to 1500 words long and are to be sent for peer-reviewed.Correspondence letters are not usually peer reviewed, but the journal might invite replies from the authors of the original publication, or pass on letters to these authors.Only two tables or figures are permitted, and there should be no more than 10 references and six authors. All accepted letters are edited, and proofs will be sent out to authors before publication.

Appendix.Reporting guidelines for study designs

Study designsRandomized controlled trial (RCT)--superiority designCONSORT statement(Begg C, et al. JAMA 1996;276:637-639.)http://jama.ama-assn.org/cgi/content/summary/276/8/637RCT with non-inferiority/equivalence designModified CONSORT statement(Piaggio G, et al. JAMA 2006;295:1152-1160.)http://jama.ama-assn.org/cgi/content/full/295/10/1152Systematic review of therapeutic interventionsQUOROM statement(Moher D, et al. Lancet 1999;354:1896-1900.)http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(99)04149-5/fulltextDiagnostic test performance studySTARD statement(Bossuyt PM, et al. Clin Chem 2003;49:1-6.)http://www.clinchem.org/cgi/content/full/49/1/1Systematic review of diagnostic testsQUADAS statement(BMC Med Res Method 2006;6(9). doi: 10.1186/1471-2288-6-9.)http://www.biomedcentral.com/1471-2288/6/9Systematic review of observational studyMOOSE statement(Stroup DF, et al. JAMA 2000;283:2008-2012.)http://jama.ama-assn.org/cgi/content/full/283/15/2008Economic evaluationsCHEC criteria(Evers S, et al. Int J Tech Assess Health Care 2005;21:240-245.)http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=292673

Notes, news or announcements for conferences,symposia or meetings may be sent for publication at least 3 months before the required date of publication.ese are mostly included under Meetings and Courses without payment. Provide title, date(s) and place of the event and contact address, telephone, and email address.Hepatobiliary & Pancreatic Diseases Internationalreserves the right to be selective in publishing these announcements.ose wishing for a detailed publication may submit as advertisements. For academic information, subsidized rates are available.

Letter of copyright transfer

We require a letter of copyright transfer signed by all named authors, stating that they have taken a significant and active part in the preparation of the article, that they have read and approved the final version, and are willing to discuss it in detail.is is essential for the reviewing process to be completed. Possibly duplicative materials (i.e.,those containing substantially similar content or using the same or similar data) that have been previously published or are being considered elsewhere must be provided at the time of manuscript submission.

To conform with theCopyright Act of China, this letter must contain the following paragraph:

In consideration ofHepatobiliary & Pancreatic Diseases Internationalreviewing and editing my (our) submission, the author(s) undersigned hereby transfer(s),assign(s), or otherwise conveys all copyright ownership toHepatobiliary & Pancreatic Diseases Internationalrepresent(s) that he (they) own(s) all rights in the material submitted.e author(s) further confirm(s) that the article is original, that it is not under consideration by another journal in any language, and that it has not been previously published, in whole or in part, in another journal in any language.ere is no conflict of interests relevant to the study reported in this article.

For convenience potential author can download the form of the letter from our journal's website.is assignment is to take effect only if the work is accepted for publication inHepatobiliary & Pancreatic Diseases International.

Letter of Copyright Transfer

Your name (printed)

Tel Fax

Email

Manuscript entitled:

We have taken a significant and active part in the preparation of the article, and we have read and approved the final version. We are willing to discuss it in detail.

In consideration ofHepatobiliary & Pancreatic Diseases Internationalreviewing and editing my(our) submission, the author(s) undersigned hereby transfer(s),assign(s), or otherwise conveys all copyright ownership toHepatobiliary & Pancreatic Diseases Internationalrepresent(s) that he(they) own(s) all rights in the material submitted.e author(s) further confirm(s) that the article is original, that it is not under consideration by another journal in any language, and that it has not been previously published, in whole or in part, in another journal in any language.ere is no conflict of interests relevant to the study reported in this article.

Authors' name(s) in order of appearance in the manuscript, signatures (date):

1. Full name (printed):Abbreviated name in PubMed (printed):Signed (handwritten):Date:

2. Full name (printed):Abbreviated name in PubMed (printed):Signed (handwritten):Date:

3. Full name (printed):Abbreviated name in PubMed (printed):Signed (handwritten):Date:

or will be

from a commercial party related directly or indirectly to the subject of this article.

Email

10.1016/S1499-3872(17)60067-5)